FDA Approves Secukinumab for Adults With HS FDA Approves Secukinumab for Adults With HS

This marks the second FDA-approved agent for the condition, and the first IL-17A inhibitor.FDA Approvals
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Dermatology News Alert Source Type: news